H.C. Wainwright Initiates Heat Biologics At Buy

By: via Benzinga
H.C. Wainwright initiated coverage on Heat Biologics Inc (NASDAQ: HTBX) with a Buy rating. The target price for Heat Biologics is set ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.